279 related articles for article (PubMed ID: 17368973)
1. Routes of delivery for progesterone and progestins.
Sitruk-Ware R
Maturitas; 2007 May; 57(1):77-80. PubMed ID: 17368973
[TBL] [Abstract][Full Text] [Related]
2. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
Sitruk-Ware R
Climacteric; 2007 Oct; 10(5):358-70. PubMed ID: 17852138
[TBL] [Abstract][Full Text] [Related]
3. Parenteral administration of progestins for hormonal replacement therapy.
Nath A; Sitruk-Ware R
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):88-96. PubMed ID: 19340703
[TBL] [Abstract][Full Text] [Related]
4. Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women.
Noé G; Sitruk-Ware R; Zegers-Hochschild F; Variano B; Montero JC; Arriagada P; Li A; Stanczyk FZ; Felix JC; Mishell DR; Croxatto HB
Climacteric; 2010 Oct; 13(5):433-41. PubMed ID: 20642326
[TBL] [Abstract][Full Text] [Related]
5. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
6. The levonorgestrel intrauterine system for use in peri- and postmenopausal women.
Sitruk-Ware R
Contraception; 2007 Jun; 75(6 Suppl):S155-60. PubMed ID: 17531609
[TBL] [Abstract][Full Text] [Related]
7. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
Baker VL
Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive devices: intravaginal and intrauterine delivery systems.
Benagiano G; Gabelnick H; Farris M
Expert Rev Med Devices; 2008 Sep; 5(5):639-54. PubMed ID: 18803474
[TBL] [Abstract][Full Text] [Related]
9. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
10. Intravaginal oestrogen and progestin administration: advantages and disadvantages.
Cicinelli E
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):391-405. PubMed ID: 17981510
[TBL] [Abstract][Full Text] [Related]
11. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
Archer DF
Semin Reprod Med; 2005 May; 23(2):188-95. PubMed ID: 15852205
[TBL] [Abstract][Full Text] [Related]
12. Transdermal natural progesterone cream for postmenopausal women: inconsistent data and complex pharmacokinetics.
Elshafie MA; Ewies AA
J Obstet Gynaecol; 2007 Oct; 27(7):655-9. PubMed ID: 17999287
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of progestins.
Sitruk-Ware R
Maturitas; 2004 Apr; 47(4):277-83. PubMed ID: 15063480
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous estradiol gel with an intrauterine levonorgestrel releasing device or natural progesterone in hormone replacement therapy.
Suvanto-Luukkonen E; Sundström H; Penttinen J; Läärä E; Pramila S; Kauppila A
Maturitas; 1997 Apr; 26(3):211-7. PubMed ID: 9147353
[TBL] [Abstract][Full Text] [Related]
15. Progestins in HRT: sufferance or desire?
Skouby SO; Jespersen J
Maturitas; 2009 Apr; 62(4):371-5. PubMed ID: 19203850
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
[TBL] [Abstract][Full Text] [Related]
17. Hormone therapy effects on social behavior and activity levels of surgically postmenopausal cynomolgus monkeys.
Shively CA; Wood CE; Register TC; Willard SL; Lees CJ; Chen H; Sitruk-Ware RL; Tsong YY; Cline JM
Psychoneuroendocrinology; 2007; 32(8-10):981-90. PubMed ID: 17768011
[TBL] [Abstract][Full Text] [Related]
18. The role of new progestins in women's health.
Dickerson VM
Int J Fertil Womens Med; 2003; 48(4):173-81. PubMed ID: 13677550
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery systems for hormone therapy.
Yoo JW; Lee CH
J Control Release; 2006 May; 112(1):1-14. PubMed ID: 16530874
[TBL] [Abstract][Full Text] [Related]
20. Levonorgestrel-releasing intrauterine system as an adjunct to estrogen for the treatment of menopausal symptoms--a review.
Peled Y; Perri T; Pardo Y; Kaplan B
Menopause; 2007; 14(3 Pt 1):550-4. PubMed ID: 17224852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
